N
Nigar Dirican
Researcher at Süleyman Demirel University
Publications - 19
Citations - 214
Nigar Dirican is an academic researcher from Süleyman Demirel University. The author has contributed to research in topics: Vasculitis & Lung cancer. The author has an hindex of 6, co-authored 19 publications receiving 155 citations.
Papers
More filters
Journal ArticleDOI
Thiol/disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer?
Nigar Dirican,Ahmet Dirican,Orhan Sen,Ayşe Aynali,Sule Atalay,Haci Ahmet Bircan,Önder Öztürk,Serpil Erdogan,Munire Cakir,Ahmet Akkaya +9 more
TL;DR: In advanced stage NSCLC, the nativeThiol, total thiol, and disulfide levels decrease, while the native thiol/disulfide ratio does not change, according to the cut-off value.
Journal ArticleDOI
The clinical significance of hematologic parameters in patients with sarcoidosis
TL;DR: The aim of this study was to evaluate the potential clinical usefulness of hematologic markers in Sarcoidosis to assess the prognosis of this disease.
Journal ArticleDOI
Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.
TL;DR: Investigation of TILs and inflammation markers in with patients advanced stage NSCLC and the association of their levels with prognosis found the relationship between the two pronostic factors remains unclear.
Journal ArticleDOI
A New Inflammatory Prognostic Index, Based on C-reactive Protein, the Neutrophil to Lymphocyte Ratio and Serum Albumin is Useful for Predicting Prognosis in Non-Small Cell Lung Cancer Cases
Nigar Dirican,Ahmet Dirican,Ceyda Anar,Sule Atalay,Önder Öztürk,Ahmet Bircan,Ahmet Akkaya,Munire Cakir +7 more
TL;DR: The IPI may be an inexpensive, easily accessible and independent prognostic index for NSCLC patients, useful for clinical practice and subgroup analysis showed IPI was generally a significant prognostic factor in all clinical variables.
Journal ArticleDOI
Silibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stress.
Serdar Kalemci,Yaşar Topal,Serkan Yaşar Çelik,Nigar Yilmaz,Halil Beydilli,Mehmet Ilkay Kosar,Nigar Dirican,Irfan Altuntas +7 more
TL;DR: Administration of silibinin was shown to ameliorate the MTX-induced pulmonary toxicity, as indicated by the normalization of the oxidative stress parameters.